Cardiovascular Disease Doctors in Oak Ridge, TN Accepting Medicare

4 Cardiovascular Disease doctors found. Showing 1 - 4

Victor W Mclaughlin, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 80 Vermont Ave, Oak Ridge, TN 37830 Phone: 865-482-4078    Fax: 865-482-4960

James Scott Halama, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 80 Vermont Ave, Oak Ridge, TN 37830 Phone: 865-482-4078    Fax: 865-482-4960

James R Michel, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 80 Vermont Ave, Oak Ridge, TN 37830 Phone: 865-482-4078    Fax: 865-482-4960

Milan J Sheth, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 80 Vermont Ave., Oak Ridge, TN 37830 Phone: 865-482-4078    Fax: 865-482-4960

News Archive

Symptoms and outcomes of 3.32 million people tested for SARS-CoV-2

A recent study published on the preprint server medRxiv* in October 2020 shows the need for large-scale studies on the clinical characteristics and outcomes of COVID-19 at the national and international scale. This is essential to shape interventions and optimize the use of resources to contain and manage a second wave of the pandemic.

Study shows bromances can improve men's health, reduce stress

Male friendships, portrayed and often winked at in bromance movies, could have healthful effects similar to those seen in romantic relationships, especially when dealing with stress, according to a new study of male rats by researchers at the University of California, Berkeley.

New version of gene editing technique corrects molecular mistakes in RNA-based diseases

Until recently, the CRISPR-Cas9 gene editing technique could only be used to manipulate DNA. In a 2016 study, University of California San Diego School of Medicine researchers repurposed the technique to track RNA in live cells in a method called RNA-targeting Cas9 (RCas9).

Brookstone Pharmaceuticals changes its name to Acella Pharmaceuticals

Brookstone Pharmaceuticals, an emerging specialty pharmaceutical company, announced today its decision to change the name of the company to Acella Pharmaceuticals, LLC. This decision has been made to create a company image and brand that more accurately mirrors our commitment to "Accelerating the Health Care Solution" by bringing quality affordable products to customers and patients. Mark Pugh, CEO states, "As we have grown over the last few years, we have evolved into a more integrated pharmaceutical company.

Read more Medical News

› Verified 9 days ago